Cargando…

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series

Background: Cefiderocol is a novel parenteral siderophore cephalosporin, demonstrating enhanced activity against multidrug-resistant (MDR) Gram-negative bacteria and difficult-to-treat Acinetobacter baumannii (DTR-AB). Plasma-free trough concentration (fC(trough)) over the minimum inhibitory concent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mornese Pinna, Simone, Corcione, Silvia, De Nicolò, Amedeo, Montrucchio, Giorgia, Scabini, Silvia, Vita, Davide, De Benedetto, Ilaria, Lupia, Tommaso, Mula, Jacopo, Di Perri, Giovanni, D’Avolio, Antonio, De Rosa, Francesco Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774561/ https://www.ncbi.nlm.nih.gov/pubmed/36551485 http://dx.doi.org/10.3390/antibiotics11121830

Ejemplares similares

Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN)
por: Lupia, Tommaso, et al.
Publicado: (2022)

2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
por: Lupia, Tommaso, et al.
Publicado: (2020)

Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections
por: Stroffolini, Giacomo, et al.
Publicado: (2022)

COVID-19 pneumonia: do not leave the corticosteroids behind!
por: Pinna, Simone Mornese, et al.
Publicado: (2021)

Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm?
por: Mornese Pinna, Simone, et al.
Publicado: (2021)

Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience
por: Lupia, Tommaso, et al.
Publicado: (2022)

Predictors of mortality in patients with COVID-19 infection in different health-care settings: A retrospective analysis from a CORACLE study group
por: Boglione, Lucio, et al.
Publicado: (2023)

Long-Term Pharmacokinetics of Dalbavancin in ABSSSI and Osteoarticular Settings: A Real-Life Outpatient Context
por: De Nicolò, Amedeo, et al.
Publicado: (2021)

New cephalosporins for the treatment of pneumonia in internal medicine wards
por: Lupia, Tommaso, et al.
Publicado: (2020)

Nodular Cutaneous Lesions in Immune-Compromised Hosts as a Clue for the Diagnosis of Disseminated Nocardiosis: From Bedside to Microbiological Identification
por: De Benedetto, Ilaria, et al.
Publicado: (2022)

The Diagnostic Relevance of β-D-Glucan for Candidemia within Internal Medicine Wards
por: Corcione, Silvia, et al.
Publicado: (2022)

A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
por: Baietto, Lorena, et al.
Publicado: (2014)

Antibiotic De-escalation Experience in the Setting of Emergency Department: A Retrospective, Observational Study
por: Corcione, Silvia, et al.
Publicado: (2021)

Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection in Solid Organ Transplant Recipients: A Single-Center, Retrospective Study
por: Pagani, Nicole, et al.
Publicado: (2021)

Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS)
por: Corcione, Silvia, et al.
Publicado: (2022)

Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with?
por: Corcione, Silvia, et al.
Publicado: (2023)

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
por: Lupia, Tommaso, et al.
Publicado: (2022)

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
por: Allegra, Sarah, et al.
Publicado: (2017)

Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality
por: Corcione, Silvia, et al.
Publicado: (2022)

Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study
por: Corcione, Silvia, et al.
Publicado: (2021)

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy
por: Cusato, Jessica, et al.
Publicado: (2022)

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants
por: Cusato, Jessica, et al.
Publicado: (2022)

Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy
por: Manca, Alessandra, et al.
Publicado: (2023)

Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2021)

Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments
por: Lupia, Tommaso, et al.
Publicado: (2023)

Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients
por: De Nicolò, Amedeo, et al.
Publicado: (2021)

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring
por: Cusato, Jessica, et al.
Publicado: (2021)

Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening
por: De Nicolò, Amedeo, et al.
Publicado: (2021)

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians
por: Principe, Luigi, et al.
Publicado: (2022)

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting
por: Perea, José Ramón Azanza, et al.
Publicado: (2022)

Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry
por: Lupia, Tommaso, et al.
Publicado: (2022)

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
por: Bilal, Muhammad, et al.
Publicado: (2021)

Giardiasis reactivation during severe SARS-CoV-2 infection
por: Lupia, Tommaso, et al.
Publicado: (2021)

COVID-19: in the uncertainty, do not try this at home
por: Lupia, Tommaso, et al.
Publicado: (2020)

Microbiome in the setting of burn patients: implications for infections and clinical outcomes
por: Corcione, Silvia, et al.
Publicado: (2020)

Personalized stewardship and interdisciplinarity: key elements of COVID-19
por: Lupia, Tommaso, et al.
Publicado: (2021)

Novel Cephalosporins in Septic Subjects and Severe Infections: Present Findings and Future Perspective
por: Corcione, Silvia, et al.
Publicado: (2021)

Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2021)

The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries
por: Trunfio, Mattia, et al.
Publicado: (2021)

COVID-19: A Possible Contribution of the MAPK Pathway
por: Cusato, Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a66bp63m6l747vmvnj909d4lvl